Article Figures & Data
Figures
- Figure 1.
Monthly costs of care for colorectal cancer patients by length of survival.
- Figure 2.
Incidence and prevalence costs of cancer care.
- Figure 3.
A, estimates of the national expenditures for cancer care in the United States in 2010 (in billions of dollars), by cancer site and phase of care. B, estimates of the proportion of national expenditures for cancer care in the United States in 2010 (in billions of dollars), by cancer site and phase of care.
- Figure 4.
Estimates of national expenditures for selected cancers in 2010 and 2020: impact of assumptions about trends in incidence, survival, and costs of care.
Tables
- Table 1.
Characteristics of selected data sources/research resources in the United States for estimating burden of cancer
Description SEER-Medicare MEPS H-CUP MCBS CRN SEER tumor registries linked to Medicare claims National household, medical provider, and insurance survey Inpatient discharge data from sampled hospitals National survey linked to Medicare claims Research centers in managed care organizations Data characteristics National or nationally representative Geographically defined √ √ √ Geographically defined Individual-level longitudinal data √ 5 panels over 2 y √ √ Approximate number of cancer survivors in 2007 >1,000,000 <2,000 >1,000,000 <2,000 >400,000 Duration of information Medicare eligibility through death 2 y Hospital admission through discharge Multiple years Enrollment through disenrollment or death Health insurance type Medicare fee-for-service only All payors All payors All payors Managed care only Patients' information Age distribution Aged 65+ or disabled (any age) Aged 18+ All ages Aged 65+ or disabled (any age) All ages Information about patients without cancer In cancer registry regions √ √ √ √ Cancer information Cancer diagnosis Registry, procedure, or diagnosis codes Self-report, procedure, or diagnosis codes Procedure or diagnosis codes Self-report, procedure, or diagnosis codes Registry, procedure, or diagnosis codes Stage at diagnosis √ √ Treatment √ √ Inpatient hospital only √ √ Type of cost estimate Incidence √ √ Prevalence in a specific year √ √ √ √ √ Direct medical cost components Hospital √ √ √ √ √ Physician and other outpatient services √ √ √ √ Outpatient pharmacy √a √ √a √ Out of pocket √ √ Indirect cost components Productivity loss (e.g., days lost from work) √ Patient time √ Caregiver time Abbreviations: SEER-Medicare, Surveillance Epidemiology and End Results-Medicare; MEPS, Medical Expenditure Panel Survey; H-CUP, Healthcare Cost and Utilization Project; MCBS, Medicare Current Beneficiary Survey; CRN, Cancer Research Network.
-
↵aData on Medicare part D prescription drug services are available starting in 2006. Before 2006, drugs administered parenterally and their administration was covered by Medicare part B, as were prodrugs, the oral drug equivalent of drugs administered parenterally.
-
Volume 20, Issue 10
